Individuals Stopping Weight-Loss Medications Gain Back Weight Far More Rapidly Than Those on Conventional Diets

Illustration of medical syringe and scale
Weight management often requires long-term strategies.

Fresh analysis indicates that people who discontinue popular weight-loss injections like Wegovy and Mounjaro can put back on lost weight far faster than those who stop traditional diet and exercise regimens.

Published data in a major health publication demonstrates that while overweight people can lose about a fifth of their body weight while using the jabs, the weight is regained at an average rate of 0.8 kg per month upon discontinuation.

"People buying such medications need to be aware of the danger of fast rebound weight gain when the treatment is stopped," stated researcher Dr. Susan Jebb.

That rate of regain implies a return to original weight within about 18 months.

Weighing Treatments

The analysis, which reviewed dozens of trials involving over 9,000 of patients, compared the results of GLP-1 agonists with older methods.

Researchers point out that people who lose weight through lifestyle changes alone typically experience a more gradual weight regain—perhaps 100 grams monthly—post-intervention.

Understanding the Rapid Regain

Experts believe the way of the jabs is key to understanding the heightened regain.

GLP-1 drugs imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Sustained high doses of the hormone levels several times higher than normal could lead to the system to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a dietetics expert.

"Discontinuation of this medication means hunger is unsuppressed, making excessive eating far more likely."

A Lifelong Disease?

Medical guidelines suggest the jabs for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Professionals say that, due to the high risk of weight regain, the therapy might need to be long-term.

This opinion is reinforced by pharmaceutical companies, who note that the findings "emphasize the chronic nature of obesity," comparing it to managing conditions like high blood pressure.

Patient Experiences

People who have discontinued the medication explain a intense resurgence of hunger.

"It felt as if a trigger flipping and you're instantly starving," said a patient.

This challenge is exacerbated if individuals have not developed lasting dietary or behavioural modifications during treatment.

Widespread Use

Recent estimates show that millions of people in the UK have used these injections in the past year, with desire remaining high.

  • Adoption is greater among women compared to men.
  • The middle-aged age group shows the greatest level of interest.
  • Many access the medications through private prescriptions rather than public health services.

Finally, clinicians caution that while the jabs are effective tools for weight loss, they are not a permanent cure and maintained weight loss likely depends on ongoing behavioural support.

William Adkins
William Adkins

Maya is an urban planner and writer passionate about sustainable city living, sharing her expertise on community development and eco-friendly practices.

April 2026 Blog Roll